Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study

BMC Pulmonary Medicine

Jing Zhao²  Hongmin Wu²  Lei Zhang¹  Na Chen¹  Ning Zhang¹  Jiaxi Yu¹  Pan Zhang¹  Peipei Chen¹  Yanan Zhu²  Peian Lou¹ 

[1] Xuzhou Center for Disease Control and Prevention, 142 West Erhuan Road, Xuzhou, 221006, China;Department of Respiratory Medicine, Affiliated Hospital of Xuzhou Medical College, 99 West Huaiai Road, Xuzhou, 221006, China

关键词: Hospital Anxiety and Depression Scale;    Depression;    Anxiety;    Chronic obstructive pulmonary disease;   

Others  :  1161066
DOI  :  10.1186/1471-2466-12-53

 received in 2011-09-30, accepted in 2012-08-31,  发布年份 2012

【 摘 要 】

Background

Patients with chronic obstructive pulmonary disease (COPD) often experience depression and anxiety, but little information is available regarding Chinese patients with these conditions. The present study assessed depression and anxiety in Chinese patients with COPD.

Methods

A case–controlled study was designed with 1100 patients with COPD enrolled in the case group and1100 residents without COPD and respiratory symptoms selected as the control group. Anxiety and depression in both groups were evaluated using the Hospital Anxiety and Depression Scale (HADS). The body mass index,degree of airflow obstruction, dyspnea, and exercise capacity (BODE ) index was used to assess COPD severity. Binary logistic regression models were used to test the association between anxiety and depression.

Results

The patients with COPD were more likely than controls to experience depression (cases, HADS 10.5 ± 3.6, prevalence 35.7%; controls, HADS 8.7 ± 2.7, prevalence 7.2%) and anxiety (cases, HADS 10.4 ± 3.1, prevalence 18.3%; controls, HADS 8.6 ± 2.1, prevalence 5.3%). Subjects with anxious and depressive symptoms had poorer health outcomes including a higher BODE index, a shorter 6-minute-walk distance (6MWD), more dyspnea, and a higher St George’s respiratory questionnaire (SGRQ) score. The prevalence of anxious and depressive symptoms increased with increasing BODE scores. On the basis of binary logistic regression, the BODE index was significantly correlated with anxiety (OR = 1.47, p < 0.001) and depression (OR = 1.51, p < 0.001). Anxious and depressive symptoms were also associated with several factors including younger age, female sex, higher education level, lower household income and history of smoking.

Conclusions

This study confirmed the high prevalence of anxiety and depression in Chinese outpatients with COPD. Patients with COPD who had anxiety and/or depression had a poorer health-related quality of life.

Trial registration

Chinese Clinical Trials Registration(ChiCTR-TRC-12001958)

【 授权许可】

   
2012 Lou et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. 2009. Available from: www.goldcopd.com webcite. Accessed 2010 May 12
• [2]Buist AS, Vollmer WM, McBurnie MA: Worldwide burden of COPD in high- and low-income countries. Part I. The burden of obstructive lung disease (BOLD) initiative. Int J Tuberc Lung Dis 2008, 12:703-708.
• [3]Mannino DM, Buist AS: Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007, 370:765-773.
• [4]Mathers CD, Loncar D: Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006, 3:e442.
• [5]Global Initiative for Chronic Obstructive Lung Disease (GOLD): Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease. 2009. Available at: http://www.goldcopd.com/Guidelineitem.asp?l1=2&l2=1&intId=2003 webcite. Accessed 2010 Apr 15
• [6]Gosselink R, Troosters T, Decramer M: Peripheral muscle weakness contributes to exercise limitation in OOPD. Am J Respir Crit Care Med 1996, 153:976-980.
• [7]Mador MJ, Deniz O, Aggarwal A, et al.: Quadriceps fatigability after single muscle exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003, 168:102-108.
• [8]Schols AM, Soeters P, Dingemans M, et al.: Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993, 147:1151-1156.
• [9]Mikkelsen RL, Middelboe T'P, Pisinger C, et al.: Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD):a review. Nord J Psychianty 2004, 58:65-70.
• [10]Ng TP, Niti M, Tan WC, et al.: Depressive symptoms and chronic obstructive pulmonary disease:effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intem Med 2007, 167:60-67.
• [11]Xu W, Collet JP, Shapiro S, et al.: Independent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizations. Am J Respir Crit Care Med 2008, 178:913-920.
• [12]America Thoracic Society: Standardization of spirometry 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136.
• [13]Bjelland I, Dahl AA, Haug TT, et al.: The validity of the Hospital Anxiety and Depression Scale: an updated literature review. J Psychosom Res 2002, 52:69-77.
• [14]Jones PW, Quirk FH, Baveystock CM, et al.: A self-complete measure of health status for chronic airflow limitation: the St. George’s Respiratory questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
• [15]Global Initiative for Chronic Obstructive Lung Disease(GOLD): The Global Strategy for the Diagnosis, Management and Prevention of COPD. 2006. Accessed July 10, 2007 at http://www. goldcopd.org webcite
• [16]Zigmond AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
• [17]Jones PW: Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002, 19:384-404.
• [18]Bestall JC, Paul EA, Garrod R, et al.: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54:581-586.
• [19]American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
• [20]Celli BR, Cote CG, Marin JM, et al.: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004, 350(10):1005-1012.
• [21]Hajiro T, Nishimura K, Tsukino M, et al.: Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 158(4):1185-1189.
• [22]Martinez FJ, Han MK, Andrei AC, et al.: Longitudinal change in the BODE index predicts mortality in severe emphysema. Am J Respir Crit Care Med 2008, 178(5):491-499.
• [23]Ong KC, Lu SJ, Soh CS: Does the multidimensional grading system (BODE) correspond to differences in health status of patients with COPD? Int J Chron Obstruct Pulmon Dis 2006, 1(1):91-96.
• [24]Ong KC, Earnest A, Lu SJ: A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005, 128:3810-3816.
• [25]Funk GC, Kirchheiner K, Bughuber OC, et al.: BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study. Respir Res 2009, 10:1. BioMed Central Full Text
• [26]Eisner MD, Blanc PD, Yelin EH, et al.: The influence of anxiety on health outcomes in COPD. Thorax 2010, 65(3):229-234.
• [27]Kunik ME, Roundy K, Veazey C, et al.: Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. Chest 2005, 127:1205-1211.
• [28]Cleland JA, Lee AJ, Hall S: Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients. Fam Pract 2007, 24:217-223.
• [29]Moussas G, Tselebis A, Karkanias A, et al.: A comparative study of anxiety and depression in patients with bronchial asthma, chronic obstructive pulmonary disease and tuberculosis in a general hospital of chest diseases. Ann Gen Psychiatry 2008, 7:7. BioMed Central Full Text
• [30]Ryu YJ, Chun EM, Lee JH, et al.: Prevalence of Depression and Anxiety in Outpatients with Chronic Airway Lung Disease. Korean J Intern Med 2010, 25:51-57.
• [31]Laurin C, Lavoie KL, Bacon SL, et al.: Sex differences in the prevalence of psychiatric disorders and psychological distress in patients with chronic obstructive pulmonary disease. Chest 2007, 132:148-155.
• [32]Di Marco F, Verga M, Reggente M, et al.: Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med 2006, 100(10):1767-1774.
• [33]Wagena EJ, Arrindell WA, Wouters EF, et al.: Are patients with COPD psychologically distressed? Eur Respir J 2005, 26:242-248.
• [34]van Manen JG, Bindels PJ, Dekker FW, et al.: Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002, 57:412-416.
• [35]Medinas-Amorós M, Alorda C, Renom F, et al.: Quality of life in patients with chronic obstructive pulmonary disease: the predictive validity 0f the BODE index. Chron Respir Dis 2008, 5:7-11.
• [36]Funk GC, Kirchheiner K, Burghuber OC, et al.: BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD-a cross-sectional study. Respir Res 2009, 10:1. BioMed Central Full Text